Molecular data suggest that these highly proliferative carcinoid tumors tend to have mutations (e.g., MEN1) more characteristic of typical carcinoids rather than RB1 or TP53 alterations that are typical of NECs [22]. The gene discussed is MEN1; the disease is carcinoid tumor.